PAS
OFIX icon

Point72 Asia (Singapore)’s Orthofix Medical OFIX Stock Holding History

Point72 Asia (Singapore)’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,195
Closed -$20.9K – 1116
2024
Q4 		$20.9K Sell
1,195
-16,100
-93% -$280K 0.01% 660
2024
Q3 		$270K Buy
+17,295
New +$277K 0.05% 307
2024
Q2 		– Sell
-29,711
Closed -$431K – 1373
2024
Q1 		$431K Buy
29,711
+25,756
+651% +$356K 0.11% 192
2023
Q4 		$53.3K Buy
+3,955
New +$46.5K 0.01% 297

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $428M AUM 136.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Point72 Asia (Singapore)'s OFIX Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Orthofix Medical (OFIX) in Q1 2025, closing a stake of 1,195 shares — an estimated $20.9K sold.

Point72 Asia (Singapore) first reported a position in OFIX in Q4 2023 and held it in 4 quarters. The position peaked at $431K in Q1 2024. 160 funds tracked by Wall St. Rank hold OFIX as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining Orthofix Medical position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 1,195 Orthofix Medical shares in Q1 2025, an estimated $20.9K.
  • Point72 Asia (Singapore) first reported a position in Orthofix Medical in Q4 2023 and held it in 4 quarters.
  • Point72 Asia (Singapore)'s Orthofix Medical position peaked at $431K in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.